Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency

Esquinas Esquinas Lopez (Lleida, Spain), Cristina Esquinas, Miriam Barrecheguren, Esther Rodriguez, Maria Sucena, Sandra Fernandez, Marc Miravitlles

Source: International Congress 2015 – COPD: chronic disease and comorbidities
Session: COPD: chronic disease and comorbidities
Session type: Thematic Poster Session
Number: 682
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Esquinas Esquinas Lopez (Lleida, Spain), Cristina Esquinas, Miriam Barrecheguren, Esther Rodriguez, Maria Sucena, Sandra Fernandez, Marc Miravitlles. Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency. Eur Respir J 2015; 46: Suppl. 59, 682

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015

Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015


The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


Results of a case-detection programme for α1-antitrypsin deficiency in COPD patients
Source: Eur Respir J 2005; 26: 616-622
Year: 2005



Screening for alpha1-antitrypsin deficiency at a university hospital
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016


Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Patients’ adherence to chronic treatment of pulmonary diseases
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015

Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres
Source: Eur Respir J 2010; 35: 960-968
Year: 2010



Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002



Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Smoke exposure as a determinant of autoantibody titre in alpha 1-antitrypsin deficiency and COPD
Source: Eur Respir J 2011; 37: 32-38
Year: 2011



Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency.
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018


Prevalence of vitamin D deficiency in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013